In malignant hypercalcaemia with low phosphate, low vitamin D, and low PTH, what should be replaced first? Denosumab was not given due to low phosphate.
Tripdatabase;
In malignant hypercalcaemia with low phosphate, low vitamin D, and low PTH, what should be replaced first? Denosumab was not given due to low phosphate.
In cases of malignant hypercalcemia with low phosphate, it may be prudent to correct phosphate levels prior to initiating treatments like denosumab, which could exacerbate hypophosphatemia.